article thumbnail

Patient experience with Social Prescribing Program in Ontario, Canada [Social determinants and vulnerable populations]

Annals of Family Medicine

Context Social Prescribing (SP) is an approach to help individuals address their health and social needs wherein a healthcare practitioner refers patients to non-clinal services in the community. Models of SP vary, and the experience of patients across these models is less known.

Patients 130
article thumbnail

Differences in primary care utilization by primary care availability in the first year of Virginia Medicaid Expansion [Health care disparities]

Annals of Family Medicine

Importantly, Virginia's Medicaid expansion reduced cost-related barriers to accessing care for over 700,000 individuals. Setting or Dataset: 2019-2020 Virginia Department of Medical Assistance Services database (demographic, enrollment, and claims data). Of these, 117,481 (57.2%) individuals had at least one primary care visit.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Overall medication adherence as an indicator for health outcomes among elderly patients with hypertension and diabetes [Diabetes and endocrine disease]

Annals of Family Medicine

Objectives To assess overall medication adherence as an indicator for emergency room (ER) visits, hospitalizations, and mortality among elderly patients. Methods The study included individuals aged 75 to 90 years, diagnosed with diabetes or hypertension, who were treated with at least one antihypertensive, or antidiabetic medication in 2017.

article thumbnail

Should We Screen for Atrial Fibrillation? ESC Says Yes (2024), Evidence Says…?

Family Medicine Initiative

ACC/AHA/ACCP/HRS Guideline (2023): “It is not yet established that patients at high risk of developing AF by a validated risk score benefit from screening.” UK National Screening Committee (2019): “Screening is not currently recommended for this condition.” Both showed no significant benefit. Here are some insights.

Screening 130
article thumbnail

Aftershock in Academia: Assessing COVID-19s Impact on Schizophrenia Patients in Academic Medical Centers [Behavioral, psychosocial, and mental illness]

Annals of Family Medicine

Context: The impact of the COVID-19 pandemic on individuals with schizophrenia who are admitted to academic medical centers (AMCs) has not been previously reported. Objective: To examine the epidemiology and mortality among schizophrenia patients discharged from AMCs in the U.S. from Oct 2019 to Dec 2023.

article thumbnail

Position Statement on Measurement Based Care

Integrated Care News by CFHA

MBC entails equal emphasis on the phases of Collect, Share, and Act , which include repeated data gathering, communication/review of the data with the patient and team, and adjusting treatment based on this information. (2) MBC enhances therapeutic alliance and improves culturally informed care to diverse patient groups. (10,

article thumbnail

Health and Mood Benefits of Semaglutide in HF

Physician's Weekly

Semaglutide therapy in patients with obese heart failure leads to marked weight loss and notable gains in mood, function, and QoL over the course of 1 year. Source: link.springer.com/article/10.1007/s00392-025-02694-5 The post Health and Mood Benefits of Semaglutide in HF first appeared on Physician's Weekly.